Finally, we were interested in evaluating the macrophage population in mice treated with defactinib compared to the controls, as it is known that macrophages support CLL progression8 and PYK2 affects both the morphology and the migration capacity of macrophages.33 Here, PTK2B is linked to B-cell chronic lymphocytic leukemia.